Literature DB >> 14520240

Elevated plasma endothelial microparticles in preeclampsia.

Vctor H González-Quintero1, Joaqun J Jiménez, Wenche Jy, Luca M Mauro, Lawrence Hortman, Mary J O'Sullivan, Yeon Ahn.   

Abstract

OBJECTIVE: The purpose of this study was to assess endothelial dysfunction in women with preeclampsia by measuring endothelial microparticles. STUDY
DESIGN: A case-control study was conducted on 20 women with preeclampsia and 20 healthy pregnant women as control subjects. Endothelial microparticles were measured by flow cytometry with anti-CD31 and anti-CD42. CD31(+)/CD42(+) platelet microparticles were also quantified.
RESULTS: Plasma endothelial microparticles levels were elevated significantly in women with preeclampsia as compared with control subjects (mean+/-SD and median [range]: 14,723+/-7,724 counts/microL and 12,378 counts/microL [1,442-33,772 counts/microL] vs 8406+/-2832 counts/microL and 9016 counts/microL [3,381-12,806 counts/microL]; P<.001). Plasma platelet microparticles levels were not different among cases compared to control subjects (10,751+/-6,114 counts/microL and 9463 counts/microL [3,000-23,895 counts/microL] vs 7871+/-4344 counts/microL and 6462 counts/microL [444-18,947 counts/microL]; P=.208). No significant correlation was found between plasma endothelial microparticles and mean arterial pressure in cases or control subjects.
CONCLUSION: The elevation of endothelial microparticles in women with preeclampsia supports the endothelial injury theory in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520240     DOI: 10.1067/s0002-9378(03)00469-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia.

Authors:  Aaron F Orozco; Carolina J Jorgez; Cassandra Horne; Deborah A Marquez-Do; Matthew R Chapman; John R Rodgers; Farideh Z Bischoff; Dorothy E Lewis
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

Review 2.  Influence of red blood cell-derived microparticles upon vasoregulation.

Authors:  Ahmed S Said; Allan Doctor
Journal:  Blood Transfus       Date:  2017-05-15       Impact factor: 3.443

Review 3.  Prediction of preeclampsia-bench to bedside.

Authors:  Anjali Acharya; Wunnie Brima; Shivakanth Burugu; Tanvi Rege
Journal:  Curr Hypertens Rep       Date:  2014-11       Impact factor: 5.369

4.  GPIbα reflects the development and progress of the patients with severe preeclampsia.

Authors:  Fu-Ju Wu; Ming-Yang Zheng; Lian-Lian Liu; Dan-Dan Wang; Xiao-Yan Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility.

Authors:  Ferhat Meziani; Angela Tesse; Eric David; M Carmen Martinez; Rosemarie Wangesteen; Francis Schneider; Ramaroson Andriantsitohaina
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

6.  Circulating endothelial microparticles in children with Henoch-Schönlein purpura; preliminary results.

Authors:  Ismail Dursun; Ruhan Düsünsel; Hakan M Poyrazoglu; Zubeyde Gunduz; Turkan Patıroglu; Harun Ulger; Metin Kaya Gurgoze
Journal:  Rheumatol Int       Date:  2010-05-25       Impact factor: 2.631

7.  Effect of different dialysis modalities on microinflammatory status and endothelial damage.

Authors:  Ana Merino; José Portolés; Rafael Selgas; Raquel Ojeda; Paula Buendia; Javier Ocaña; M Auxiliadora Bajo; Gloria del Peso; Julia Carracedo; Rafael Ramírez; Alejandro Martín-Malo; Pedro Aljama
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

Review 8.  Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles.

Authors:  Bence György; Tamás G Szabó; Mária Pásztói; Zsuzsanna Pál; Petra Misják; Borbála Aradi; Valéria László; Eva Pállinger; Erna Pap; Agnes Kittel; György Nagy; András Falus; Edit I Buzás
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 9.  NOX enzymes as novel targets for drug development.

Authors:  J David Lambeth; Karl-Heinz Krause; Robert A Clark
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

10.  Clinical CVVH model removes endothelium-derived microparticles from circulation.

Authors:  Abdelhafeez H Abdelhafeez; Paul M Jeziorczak; Terry R Schaid; Susan L Hoefs; Sushma Kaul; Rahul Nanchal; Elizabeth R Jacobs; John C Densmore
Journal:  J Extracell Vesicles       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.